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Abstract 
Purpose: Disparities in cancer treatment for geographical and socioeconomic reasons have been demonstrated in 
several countries. In Valais, a canton in Switzerland, to travel to one of the oncology wards can be time 
consuming, cost intensive and make support by relatives or external persons and institutions necessary.  
Method: We investigated which kind of support cancer patients in Valais need today to make a treatment 
possible, quantified it and identified subgroups with particular needs. All patients who came in February 2012 
for a consultation or an ambulant therapy to one of the four centres of the “Département Valaisan d’Oncologie” 
or the unique private practice in the region were asked to answer to a questionnaire. Results were summarised 
and analysed.  
Results: 84% of the patients need support. 40% of the patients need two or more kinds of support. Kind and 
quantity of support depend on gender, age and distance. Cancer patients in Valais need support to make their 
treatments possible. Some subgroups have a complex pattern of support and need specific assistance as younger 
women or elderly patients. 
Conclusions: We demonstrate that cancer patients in Valais need social support to handle their treatment days 
and that their out of the pocket travel expenses increase rapidly with distance. The pattern of support needed 
varies according to patient characteristics as gender, age and distance to treatment centre. 
Keywords: cancer, families, older patients, social support 
1. Introduction 
Disparities in cancer treatments have been shown in many countries (Byers et al., 2008; Dejardin et al., 2005; 
Eaker et al., 2009; Gori et al., 2010; Halmin et al., 2008; Haynes, Pearce & Barnett, 2008; Jones et al., 2008; 
Lejeune et al., 2010; Maddison, Asad, & Urquhart, 2011; Olver, Marine, & Grogan, 2011; Rosato et al., 2009; 
Siminoff & Ross, 2005). Influence of socioeconomic determinants on cancer treatment has been demonstrated 
(Mackenbach et al., 2008; Merletti, Galassi, & Spadea, 2011; Morimoto, Coalson, Mowat, & O’Malley, 2010; 
Senior, 2009). Having to travel for treatment cause many practical, emotional and financial problems to patients 
and burden them with additional worry concerning family and work commitments (Butow et al., 2012). Recent 
publications highlighted as well travel-related burden for cancer patients (Zucca, Boyes, Newling, Hall, & Girgis, 
2011), and financial and social impacts for support persons of cancer survivors (Carey et al., 2012) as impact of 
age and distance on the willingness of cancer patients to travel more or further away for a slightly more efficient 
therapy (Groux, Anchisi, & Szucs, 2014). 
The Swiss health system is based on principles of free demand and supply as well as regulated competition 
(Busato & Künzi, 2008) with a fee-for-service system for the reimbursement. As travel costs are not reimbursed 
they can increase the travel-related burden for patients living in remote areas.  
Valais is a Swiss alpine canton at the south-western border of the country and consists in the main Rhone river 
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valley and lateral valleys of several feeder rivers. Three quarters of the population live in the French speaking 
part, one quarter in the eastern German speaking part. The Département Valaisan d’Oncologie (DVO) offers 
treatments in four different regional hospitals (Brig, Martigny, Sion, Sierre) and runs a radio-oncology service in 
Sion. Chemotherapies are also administered by the Hôpital du Chablais-Riviera in Monthey and a private 
practice in Sierre. A former study disclosed transport issues as a major obstacle to cancer treatment for elderly 
patients (S. Anchisi & A. Anchisi, 2008). These results have been confirmed by a recent study which also 
demonstrated that cancer patients in Valais outline this issue when discussing cancer treatment with their general 
practitioner and medical oncologist (Groux & Szucs, 2013). Free transport services for patients who need help 
are offered by the local cancer league: volunteers drive the patients of the French speaking part in their private 
car and for radio-oncology patients of the German speaking part a daily bus starting in Brig and stopping at each 
railway station drives the patients to Sion, where a special time slot is reserved for them. 
We investigated the need for social support of all patients coming in February 2012 for consultation or ambulant 
therapy to one of the four centres of the DVO or to the private practice. The aim was to characterize and quantify 
the kind of support the patients required and to identify groups of patients with particular support needs. 
Approval for the study was obtained from the medical-ethical commission of the canton of Valais. 
2. Methods 
All patients coming in February 2012 for consultation or ambulant treatment to one of the four centres of the 
DVO or to the private practice were asked to answer a survey. Patients who came for the first time were 
excluded. Patients were asked to fill out the questionnaire at least once per centre. If a patient came up in two 
different centres he was asked to answer in both centres. The questionnaire covered items as gender, date of birth, 
living place, kind of cancer, kind of treatment and questions covering different aspects of the travel: how the 
patient travelled to the centre, how long the travel lasted and which kind of support was necessary to travel and 
who provided this support. 
Five forms of social support were screened:  
(1) whether patients came alone or accompanied;  
(2) whether somebody took care of children, pets etc. during the absence of the patient;  
(3) whether they needed external help at home during their absence;  
(4) which means of transport were used; and  
(5) whether they came directly from their home and if not whether they spent the night abroad to stay closer to 
the treatment centre.  
The survey was pre-tested for comprehension with a small group of twelve persons representing age groups, 
gender, languages and educational level as expected among patients of the survey. The wording was slightly 
adapted after pre-test by simplifying some questions. The relevant questions of the questionnaires are described 
in Table 1. 
The data were summarized and analyzed using Microsoft Excel and EpiData Analysis (Epidata Association, 
Odense, Denmark). Patients who answered they came alone and named an accompanying person in the sub 
question were considered with contradictory answers (28) and excluded as well as patients not living in Valais (2) 
or not having cancer (23). Patients with haematological problems without cancer are followed in the same wards. 
If a patient answered twice to the questionnaire at the same site only the first questionnaire was considered. 
 
Table 1. Excerpts of the questionnaire with all questions relevant for this publication  
Question Possible answers 
1) Did you already answer once to this questionnaire? 
 
Yes, in 
         Brig 
         Martigny 
         Sion 
         Sierre 
         Private practice in Sierre 
No 
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2) My gender is 
 
female 
male 
3) My birthday is (Day/Month/Year)    -   -      
4) I live in  Postal code ________ Location _______ 
5) I live alone Yes 
No 
6) I have the following cancer diagnosis  Prostate 
Breast 
Colon 
Lung 
Skin 
Other 
I don’t know 
I don’t have cancer 
7) Which cancer therapy do you receive today? Chemotherapy 
Radiotherapy 
Chemo- and Radiotherapy 
Other 
No cancer therapy 
8) How did you travel today to the ward? Private car 
Public transportation 
Taxi 
Transport services of the cancer league * 
Bus of radio-oncology * 
Walk 
Other 
9) How long did your journey last? Less than 15 minutes 
Less than 30 minutes 
Less than 1 hour 
More than 1 hour 
10) Did you start your journey at home? Yes 
No 
11) Did you sleep abroad to be closer to the 
treatment centre? 
Yes * 
No 
12) Did you come alone or accompanied? Alone  
Accompanied * 
13) Who takes care of your family, children, and animals 
during your absence? 
My marriage/life partner * 
My children * 
My parents * 
Other members of the family * 
Friends * 
Neighbour * 
Volunteer * 
Nobody 
I don’t need help 
14) Do you need external help during your absence? Yes * 
No 
Note. Question 12 had a sub question “if accompanied, by whom?” with the same answers as question 13 but 
the last one (I don’t need help). * Kinds of support considered in this study. 
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Table 2. Patient characteristics 
Characteristics Result 
Gender 
     Women 
     Men 
 
167 (56%) 
131 (44%) 
Median age 
     Women 
     Men 
64 years (95% CI: 63 - 65) 
60 years (95% CI: 58 - 62) 
66 years (95% CI: 64 - 68) 
Age range 19 to 87 years old 
Language 
     French 
     German 
 
199 (67%) 
99 (33%) 
Type of cancer in women 
     Breast 
     Lung 
     Colorectal 
     Others 
     Not answered 
 
84 (50%) 
17 (10%) 
13 (8%) 
46 (28%) 
7 (4%) 
Type of cancer in men 
     Colorectal 
     Prostate 
     Lung 
     Others 
     Not answered 
 
23 (18%) 
22 (17%) 
12 (9%) 
62 (47%) 
6 (5%) 
Distance to treatment centre 
     below 15 minutes 
     between 15 and 30 minutes 
     between 30 and 60 minutes 
     more than 60 minutes 
 
122 (41%) 
100 (34%) 
55 (18%) 
21 (7%) 
Reason of the visit 
     Chemotherapy 
     Radiotherapy 
     Radiotherapy plus chemotherapy 
     Other treatment e.g. for side-effects 
     No treatment e.g. consultation only 
     Not answered 
 
152 (51%) 
17 (6%) 
15 (5%) 
49 (16%) 
47 (16%) 
18 (6%) 
298 patients answered all requested questions. 
 
3. Results 
629 questionnaires were handed out from which 619 were collected. 408 different patients participated to the 
survey and 298 different patients answered all requested questions for this publication (73% of all participating 
patients). Patient characteristics are summarized in Table 2. 
251 patients (84%) needed at least one of the described kinds of support (seeTable 1), 134 (45%) needed one, 82 
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(27%) two, 33 (11%) three and 2 (1%) four kinds of support. 186 patients (62%) came accompanied, 154 (52%) 
required help at home during the treatment, 25 (8%) needed external help at home, 18 (6%) came with an offered 
transport service. Only 3 (1%) stayed closer to the hospital to reduce the distance. Among the 117 patients who 
requested at least two kinds of support, 94 times it was the combination “be accompanied” and “need for help at 
home during the absence”. 
The four distance groups (see Table 2) were not homogenous as well for the gender ratio (65% women in group 
1, 57% group 2, 33% group 3, 62% group 4) as for the median age (60 years / 64 years / 66 years / 65 years). To 
allow comparisons between distance group data were standardized for age and gender. 
Women tended to call more for support than men (Figure 1). The difference was not statistically significant for 
isolated items, but the combination of the need for an accompanying person with somebody helping at home was 
statistically significant with an OR of 2.1 (95% CI 1.3-3.5). 
 
 
Figure 1. Women tend to claim more for support than men 
 
 
Figure 2. The kind of support claimed varies by age. An accompanying person becomes more important with 
increasing age; meanwhile help at home becomes less important 
66%
56%
11% 7%
1%
57%
47%
5% 4% 2%
accompanied help @ home external help transport service external night
type of support by gender
women (n=167) men (n=131)
45%
67%
22%
12%
0%
56%
61%
4% 4%
0%
64%
50%
4% 6% 2%
78%
35%
9%
2% 1%
accompanied help @ home external help transport service external night
type of support by age group
below 50 (n=43) 50 to 59 (n=75) 60 to 69 (n=93) 70 and above (n=87)
www.ccsenet.org/cco Cancer and Clinical Oncology Vol. 3, No. 2; 2014 
32 
 
Age of the patients influences the kind of support they need (figure 2). 45% of the patients below 50 years came 
alone to the treatment but 67% needed help at home. On the other hand 78% of elderly patients (70 years old or 
above) came accompanied to the treatment but only 35% needed help at home. The percentage of accompanied 
patients increases from age group to age group and the need for help at home declines from age group to age 
group. Help at home, external assistance and transport service are particularly required by the youngest patients 
(below 50 years). The differences were statistically significant with an OR of 3.7 (95% CI 1.8 - 7.9) for help at 
home, 5.9 (95% CI 2.5 – 14.2) for external help and 3.6 (95% CI 1.3 – 10.3) for transport services. 
Distance from the place of residence to the oncology centre impacts on the type of support (figure 3). The four 
distance groups (see table 2) were not homogenous as well for the gender ratio as for the median age. To allow 
comparisons between distance group data were standardized for age and gender. Below 15 minutes a majority of 
patients (54%) travel alone, patients with a distance greater than 15 minutes travel mainly accompanied (79%), 
OR of 6.3 (95% CI 3.6-11.0). Above 60 minutes transport services gained in importance (33% of the patients 
used transport services and 40% came with an accompanying person). The percentage of patients requiring help 
at home decreases rapidly with growing distance except for the longest distance. From distance group 1 to 
distance group 3 the need drops from 67% to 35% (OR 3.5, 95% CI 1.8 – 6.9). No statistically significant 
differences are observed as well for the need for external help as for external overnight. 
 
 
Figure 3. Travel time influences the kind of support claimed. Three distinguished groups exist: those with less 
than 15 minutes to travel (distance group 1), those between 15 and 60 minutes (distance groups 2 and 3) and 
those above 60 minutes (distance group 4) 
 
4. Discussion 
To travel for cancer treatment causes many practical, emotional and financial problems to patients and caregivers, 
burdens them with additional worry concerning family and work commitments and has a financial and social 
impact for support persons of cancer survivors and the patients themselves. A journey for a cancer treatment last 
much longer than the treatment itself. The more persons are required to make the journey possible the higher 
social impact for patients and support persons is. 
We investigated how extensively cancer patients in Valais call for social support to have access to their treatment, 
focusing on the “travel problems”. We come to the conclusion, that they very frequently need support for the 
journey and during their absence from home. In fact, 8 out of 10 patients need at least one kind of support 
investigated (accompanying person for the travel, help at home, external help, free transport service and 
overnight closer to the treatment centre) to get their treatment. About 40% of patients need even two or more 
kinds of support. 
The most frequent need (62%) is to come accompanied. This doesn’t necessarily mean that patients are unable to 
come alone. We can speculate that insecurity in driving or the need to have moral support are other reasons to 
come accompanied to the ward. Somebody helping at home during the journey is nearly as frequent with 52% of 
46%
62%
8% 2% 0%
81%
47%
6% 3% 0%
80%
34%
14% 4% 5%
40%
63%
5%
33%
0%
accompanied help @ home external help transport
service
external night
age-gender adjusted type of support 
by distance group
distance group 1 (n=122) distance group 2 (n=100)
distance group 3 (n=55) distance group 4 (n=21)
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the patients having this form of support whereas external help, free transport services or sleeping closer to the 
centre concern only a minority of patients.  
Which kind of support the patients require depends on age, gender and distance to the centre. Women tend to 
require more support than men. Although difference is not statistically significant for single item she need to 
have at the same time an accompanying person and somebody helping at home during the absence for treatment 
is statistically more frequent for women. This is potentially linked to the pattern of cancer incidence with age, 
particularly breast cancer, a cancer disease with a younger patient population, and to the typical socio-family 
roles with women in charge of children education and household. 
With increasing age, most patients need help for the travel. Only 1 out of 5 elderly patients comes alone. Need 
for help at home on the contrary decreases with age. 
When the travelling distance is greater than 15 minutes, 4 of 5 patients don’t come alone, independently of age 
and gender. We assume that this is linked to the question whether the patient feels strong enough to travel alone.  
Patients living more than an hour from the treatment centre are a small minority (7%). In the French speaking 
travel part such a long journey is linked to radiotherapy, in the German speaking part journeys of more than an 
hour are also possible for chemotherapy patients. Their pattern of support differs from the pattern of the rest of 
the population. One third of them chose the free transport service offered by the cancer league. As travel 
expenses are not covered by the health care insurance, travel costs are high for these patients. For radiotherapy 
they have to travel every working day for 2 to 6 weeks. Whether these patients chose free transport to avoid 
having to pay high travel expenses cannot be answered with our data. 
Two other groups of patients need specific support: patients below 50 years of age and those 70 years and above. 
With 16% and 27% respectively they are more numerous than patients living far away from a centre. In both 
groups many persons, mainly relatives, are involved to handle the treatment days. If the patient came alone the 
life partner helped at home in 4 of 10 cases, as well for the patients in distance group 4 travelling with a transport 
service. One reason why more patients travel alone in distance group 1 and more patients use travel service in 
distance group 4 could potentially be that these patients had to choose other solutions to travel because their life 
partner had to stay at home and take care of children, animals etc. 
Patients younger than 50 years as the elderly ones require more help at home. This is probably linked to the 
family structure evolving with age. All patients requiring external help were women except one and almost one 
young woman out of four asked for external help, which is distinctly more than for other age groups. They all 
lived in a multi-person household except one, had almost always additionally a relative or the life partner taking 
care at home for children, animals etc. and a majority of these patients came accompanied, which is atypical for 
this age group. The accompanying person was always but in one case a relative or the life partner. This complex 
pattern of need for support is quite a burden for the family. 
If a patient can’t travel alone or if a patient needs somebody at home to bridge its absence e.g. to take care of 
children we can speculate that this creates a moral commitment to succeed in treatment, whatever success will 
mean in the patient’s specific situation. To mobilize relatives, friends and neighbours to make a cancer treatment 
possible increases the burden of the treatment itself and can cause wearing worry. 
The study methodology has several limitations, particularly the voluntariness to participate to the survey and to 
answer to the specific questions of interest for this investigation. Socioeconomic factors as education level, 
income class, immigration background or size of the household were not collected, bias is therefore possible. For 
example the decline of percentage of patients requiring help at home with growing distance could be biased by 
other factors, e.g. the type of cancer. We renounced to a multivariate model as our questionnaire didn’t contain 
all these relevant factors, accepting the limitation of a univariate logistic regression. The survey was done during 
winter where snow causes additional difficulties to travel. 
5. Conclusion 
We demonstrate that cancer patients in Valais need social support to handle their treatment days. Pattern of 
support needed varies according to patient characteristics as gender, age and distance to treatment centre. Most 
of this support is given by the family of the patient. Support given by the cancer league to solve transport 
problems is not negligible. Needs are particularly high for some subgroups. Further analysis of our data is 
ongoing and will be published separately. Our observational study allows generating hypothesis to explore 
reasons for the described extended extensive needs. 
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